MeCP2 Dependent Transcriptional Repression & Neurotransmission

MeCP2 依赖性转录抑制

基本信息

  • 批准号:
    10462209
  • 负责人:
  • 金额:
    $ 39.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-15 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Over the past ~15 years, we have examined the role of MeCP2 in neurotransmission as a transcriptional factor impacting gene expression. Our data has revealed that MeCP2 is a bona fide regulator of synaptic function with bidirectional changes in MeCP2 resulting in reciprocal alterations in neurotransmission. We have also shown alterations in MeCP2 expression in mice result in several behavioral phenotypes as well as deficits in specific measures of synaptic plasticity further implicating MeCP2 as a key mediator of synaptic processes. A rather surprising finding in the field of depression has been the demonstration that ketamine, an NMDA receptor antagonist, has rapid and long-lasting antidepressant responses in depressed individuals. We are investigating the mechanism of the antidepressant action of ketamine, and found that the sustained antidepressant effects are dependent on MeCP2 Ser421 phosphorylation. In contrast, the rapid antidepressant action of ketamine is not dependent on MeCP2 Ser421 phosphorylation, revealing a distinct mechanism between rapid and sustained effects. The objective of this grant is to explore the novel hypothesis that MeCP2- dependent transcriptional mechanisms underlie the sustained antidepressant effects of ketamine. We will use state of the art behavioral as well as cellular and biochemical approaches to examine our hypothesis. Collectively, these studies will contribute to a better understanding of mechanisms underlying the maintenance of antidepressant effects as well as provide novel insight into MeCP2 regulation as a therapeutic target.
项目摘要 在过去的15年里,我们研究了MeCP 2作为转录因子在神经传递中的作用 影响基因表达。我们的数据显示MeCP2是突触功能的真正调节者, MeCP2的双向变化导致神经传递的相互改变。我们还 显示小鼠中MeCP2表达的改变导致几种行为表型以及 突触可塑性的特定测量进一步暗示MeCP 2是突触过程的关键介质。一 在抑郁症领域,一个相当令人惊讶的发现是,氯胺酮,一种NMDA, 受体拮抗剂,在抑郁症患者中具有快速和持久的抗抑郁反应。我们 研究氯胺酮抗抑郁作用的机制,发现持续的 抗抑郁作用依赖于MeCP2 Ser421磷酸化。相反,快速 氯胺酮的抗抑郁作用不依赖于MeCP2 Ser421磷酸化,揭示了一种独特的 快速和持续效果之间的关系。这项资助的目的是探索新的假设 MeCP2依赖的转录机制是氯胺酮持续抗抑郁作用的基础。 我们将使用最先进的行为以及细胞和生物化学方法来检查我们的 假说.总的来说,这些研究将有助于更好地理解 维持抗抑郁作用,并为MeCP2调节作为治疗药物提供新的见解 目标

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation.
  • DOI:
    10.1038/s41593-021-00868-8
  • 发表时间:
    2021-08
  • 期刊:
  • 影响因子:
    25
  • 作者:
    Kim JW;Autry AE;Na ES;Adachi M;Björkholm C;Kavalali ET;Monteggia LM
  • 通讯作者:
    Monteggia LM
BDNF signaling in context: From synaptic regulation to psychiatric disorders.
  • DOI:
    10.1016/j.cell.2021.12.003
  • 发表时间:
    2022-01-06
  • 期刊:
  • 影响因子:
    64.5
  • 作者:
    Wang CS;Kavalali ET;Monteggia LM
  • 通讯作者:
    Monteggia LM
Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function.
A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission.
Probing the segregation of evoked and spontaneous neurotransmission via photobleaching and recovery of a fluorescent glutamate sensor.
通过光漂白和恢复荧光谷氨酸传感器的诱发和自发神经传递的分离。
  • DOI:
    10.7554/elife.76008
  • 发表时间:
    2022-04-14
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Wang, Camille S.;Chanaday, Natali L.;Monteggia, Lisa M.;Kavalali, Ege T.
  • 通讯作者:
    Kavalali, Ege T.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA M MONTEGGIA其他文献

LISA M MONTEGGIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA M MONTEGGIA', 18)}}的其他基金

ANTIDEPRESSANTS & INTRACELLULAR SIGNALING LINKED TO BDNF
抗抑郁药
  • 批准号:
    9919639
  • 财政年份:
    2018
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    8913777
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    8213471
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    7620054
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    8018665
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    8744305
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MECP2 DEPENDENT TRANSCRIPTIONAL REPRESSION & NEUROTRANSMISSION
MECP2 依赖性转录抑制
  • 批准号:
    9779449
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    7769456
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
MeCP2 Dependent Transcriptional Repression & Neurotransmission
MeCP2 依赖性转录抑制
  • 批准号:
    8658621
  • 财政年份:
    2008
  • 资助金额:
    $ 39.61万
  • 项目类别:
Region & Developmental Stage Specific Deletion of MeCP2 in Mouse Brain
地区
  • 批准号:
    7256736
  • 财政年份:
    2007
  • 资助金额:
    $ 39.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了